Abstract
Objective
To examine the validation and reliability of the distress thermometer (DT) recommended by National Comprehensive Cancer Network (NCCN) in Chinese cancer patients.
Methods
A total of 574 Chinese cancer patients from Beijing Cancer Hospital completed the detection of DT, the Hospital Anxiety and Depression Scale (HADS) and Symptom Checklist 90 (SCL-90), Receiver Operating Characteristic (ROC) curve and Area Under the Curve (AUC) were used to analyze the validation relative to HADS and SCL-90. The patients with DT≥4 and whose distress caused by emotional problems were interviewed with the MiNi International Neuro-psychiatric Interview (MINI) (Chinese Version 5.0). This version was used to analyze cancer patients’ psychological and Psychiatric symptoms during the cancer process; 3. Another 106 cancer patients in rehabilitation stage and stable condition were asked to fill in DT two times, at the base time and after 7–10 days.
Results
Data of ROC indicates that a DT cutoff score of 4 yielded AUC of 0.80 with a optimal sensitivity (0.80) and specificity (0.70) relative to HADS, and AUC of 0.83 with the greatest sensitivity (0.87) and specificity (0.72) against SCL-90. The DT also has acceptable test-retest reliability (r=0.800, P=0.000); According to the interview results, the most common psychiatric problems cancer patients have adjustment disorder, depression, and anxiety.
Conclusion
The data suggest that DT has acceptable overall accuracy and reliability as a screening tool for testing distress severity and specific problems causing distress in Chinese cancer patients. It is worth being used in oncology clinic, the rapid screening and interview could help caregivers to identify psychological and psychiatric problems of cancer patients and provide useful information for further treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
American Cancer Society & National Comprehensive Cancer Network. (2005). Distress Treatment guidelines for patients-Version II/July 2005. Retrieved October 3, 2005, Available from http://www.nccn.org/patients_gls/_english/_distress/contents.aps
Maguire P. Improving the detection of psychiatric problems in cancer patients. Soc Sci Med 1985; 20:819–823.
Zabora J, Brintzenhofeszoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology 2001; 10:19–28.
Stark D, Kiely M, Smith A, et al. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002; 20:3137–3148.
Söllner W, DeVries A, Steixner E, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001; 84:179–185.
McDonald MV, Passik SD, Dugan W, et al. Nurses’ recognition of depression in their patients with cance. Oncol Nurs Forum 1999; 26:593–599.
Bultz BD, Carlson LE. Emotional distress: the sixth vital sign in cancer care. J Clin Oncol 2005; 23:6440–6441.
Zhang YN, Zhang HW, Tang LL. Application of the NCCN Distress Thermometer in Chinese cancer Patients. Chin Ment Health J (in Chinese) 2010; 12:897–902.
Roth AJ, Kornblith AB, Batel-Copel L, et al. Rapid screening for psychological distress in men with prostate carcinoma: a pilot study. Cancer 1998; 82:1904–1908.
Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychological distress in ambulatory cancer patients. Cancer 2005; 103:1494–1502.
Shim EJ, Shi YW, Jeon HJ, et al Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list. Psychooncology 2008. 17:548–555.
Gessle S, Low J, Daniells E, et al. Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psychooncology 2008; 17:538–547.
Recklitis CJ, Licht I, Ford J, et al. Screenning adult survivors of childhood cancer with the distress thermometer: a comparison with the SCL-90-R. Psychooncology 2007; 16:1046–1049.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Distress management, version 1. 2008. Available from: http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67:361–370.
Barczak P, Kane N, Andrews S, et al. Patterns of psychiatric morbidity in a genitor-urinary clinic. A validation of the Hospital Anxiety Depression scale (HAD). Br J Psychiatry 1988; 152:698–700.
Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An update literature review. J Psychosom Res 2002; 52:69–77.
Ye WF, Xu JM. Application and evaluation of hospital anxiety and depression scale in general hospital patients. Chin Behav Med J (in Chinese) 1993; 2:17–19.
Derogatis LR. How to use the Symptom Distress Checklist (SCL-90) in clinical evaluations, Psychiatric Rating Scale, Vol II. Self-Report Rating Scale, Hoffmann-La Roche Inc.
Jin H, Wu WY, Zhang MY. Preliminary analysis of SCL-90 results in normal Chinese. Chin J Nerv Ment Dis (in Chinese) 1986; 12:260–263.
Karnofsky DA. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1:634–656.
Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using karnofsky performance status. Cancer 1980; 45:2220–2224.
Lecrubier Y, Sheehan DV, Weiller E, et al. The mini international neuropsychiatric interview (MINI). A short diagnostic structured interview: reliability and validity according to CIDI [J]. Eur Psychiatry 1997; 12:224–231.
Spitzer RL, Williams JB, Gibbon M, et al. The structured clinical interview for DSM-III-R (SCID). I. History, rationale, and description. Arch Gen Psychiatry 1992; 49:624–629.
World Health Organization. The Composite International Diagnostic Interview (CIDI), Authorized Core, Version 1.0. Geneva: WHO Press; 1990.
Si TM, Shu L, Dang WM, et al. Evaluation of the reliability and validity of Chinese version of the mini international neuropsychiatric interview in patients with mental disorders. Chin Mental Health J (in Chinese) 2009; 23:439–503.
Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. J Am Med Assoc 1983; 249:751–757.
Glover J, Dibble SL, Dodd MJ, et al. Mood states of oncology outpatients: does pain make a difference? J Pain Symptom Manage 1995; 10:120–128.
Ayres A, Hoon PW, Franzoni JB, et al. Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J Psychosom Res 1994; 38:393–402.
Lee MS, Love SB, Mitchell JB, et al. Mastectomy or conservation for early breast cancer: psychological morbidity. Eur J Cancer 1992; 28A:1340–1344.
Passik SD, Dugan W, McDonald MV, et al. Oncologists’ recognition of depression in their patients with cancer. J Clin Oncol 1998; 16:1594–1600.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, Ll., Zhang, Yn., Pang, Y. et al. Validation and reliability of distress thermometer in Chinese cancer patients. Chin. J. Cancer Res. 23, 54–58 (2011). https://doi.org/10.1007/s11670-011-0054-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11670-011-0054-y